{"id":597146,"date":"2026-01-12T08:30:14","date_gmt":"2026-01-12T14:30:14","guid":{"rendered":"https:\/\/cerebrodigital.net\/?p=597146"},"modified":"2026-03-13T17:30:15","modified_gmt":"2026-03-13T23:30:15","slug":"neurologist-takes-high-dose-of-psilocybin-and-scans-his-brain-as-it-reorganizes","status":"publish","type":"post","link":"https:\/\/cerebrodigital.net\/en\/neurologist-takes-high-dose-of-psilocybin-and-scans-his-brain-as-it-reorganizes\/","title":{"rendered":"Neurologist Takes High Dose of Psilocybin and Scans His Brain as It Reorganizes"},"content":{"rendered":"\n

Psilocybin<\/strong>, the active compound in hallucinogenic mushrooms, has sparked great interest in modern science. A unique experiment conducted by neurologist Nico Dosenbach<\/strong> revealed how this substance<\/strong> alters brain activity<\/strong>. The study, published in Nature<\/em>, opens new perspectives on neuronal plasticity<\/strong> and its potential therapeutic benefits<\/strong>.<\/p>\n\n\n\n

Nico Dosenbach’s Psilocybin Experiment<\/h2>\n\n\n\n
\"-\"<\/figure>\n\n\n\n

Nico Dosenbach<\/strong>, associate professor of neurology<\/strong> at Washington University in St. Louis<\/strong>, decided to experience the effects of psilocybin<\/strong> firsthand. With colleagues’ help, he received a high dose<\/strong> of 25 milligrams and entered a MRI machine<\/a><\/strong> to observe his own brain<\/strong> in action.<\/p>\n\n\n\n

At first, he didn’t know if he’d ingested psilocybin<\/strong> or Ritalin<\/strong>, used as a placebo<\/strong>. The uncertainty<\/strong> faded when he began feeling his mind<\/strong> transform into a computer<\/strong>. “I was the tablet, and my thoughts were like a computer’s,” he told CNN<\/em>.<\/p>\n\n\n\n

The study included seven adult participants<\/strong>, who underwent multiple scans<\/strong> before, during, and weeks after the psychedelic trip<\/strong>. Some received additional doses<\/strong> months later. Results showed psilocybin<\/strong> significantly alters the brain’s default mode<\/strong>, the network responsible for our sense of self<\/strong>, space<\/strong>, and time<\/strong>.<\/p>\n\n\n\n

This finding is key: the drug<\/strong> appears to desynchronize<\/strong> brain areas<\/strong> linked to introspective thinking<\/strong>, like daydreaming<\/strong> or remembering<\/strong>. This desynchronization<\/strong>, far from negative, opens doors to greater cognitive flexibility<\/strong>, with potential therapeutic applications<\/strong> in the future.<\/p>\n\n\n\n

Brain Desynchronization<\/h2>\n\n\n\n
\"-\"<\/figure>\n\n\n\n

The study’s lead author<\/strong>, Joshu Siegel<\/strong>, explained that psilocybin<\/strong> takes a fundamental system for self-perception<\/strong> and temporarily desynchronizes<\/strong> it. This creates an intense psychedelic experience<\/strong> short-term but leaves a positive trace in brain plasticity<\/a><\/strong>.<\/p>\n\n\n\n

Plasticity<\/strong> is the brain’s capacity<\/strong> to change<\/strong> and grow<\/strong>, considered essential in psychological recovery<\/strong> processes. According to Siegel, the long-term consequence<\/strong> is a more flexible brain<\/strong>, potentially more capable<\/strong> of reaching a healthy state.<\/p>\n\n\n\n

Scans<\/strong> showed that after the trip, brain connectivity<\/strong> doesn’t immediately return to its original state. A subtle effect persists for weeks, suggesting psilocybin<\/strong> could be a tool<\/strong> to break negative thought patterns<\/strong> and open new mental pathways<\/strong>.<\/p>\n\n\n\n

This phenomenon<\/strong> has sparked great interest in psychedelic medicine<\/strong>, a field seeking to harness these substances<\/strong> for treating disorders like depression<\/strong> or anxiety<\/strong>. However, researchers<\/strong> warn that self-medication<\/strong> is not advisable: benefits are best achieved under professional supervision<\/strong>.<\/p>\n\n\n\n

Therapeutic Implications<\/h2>\n\n\n\n
\"-\"<\/figure>\n\n\n\n

The study’s results offer a hopeful vision. Psilocybin<\/strong> not only triggers a psychedelic trip<\/strong> but also leaves a lasting effect<\/strong> on brain connectivity<\/strong>.<\/p>\n\n\n\n

Dosenbach<\/strong> noted that an initial massive impact<\/strong> is observed, followed by a small, stable effect<\/strong>. This balance is ideal for a medication<\/strong>: it doesn’t destroy brain networks<\/strong> or immediately revert them to their prior state, but maintains enough change to make a difference.<\/p>\n\n\n\n

From a psychotherapy<\/strong> perspective, this neuronal flexibility<\/strong> could help patients break harmful mental habits<\/strong> and build new ways of thinking<\/strong>. The research reinforces that psychedelics<\/strong>, used responsibly in clinical settings<\/strong>, can become allies<\/strong> in mental health<\/strong>.<\/p>\n\n\n\n

The renewed interest in these substances<\/strong> opens paths to innovative treatments<\/strong>, where science<\/strong> and subjective experience meet to transform how we understand the human mind<\/strong>.<\/p>\n\n\n\n

The study led by Dosenbach demonstrates that psilocybin can desynchronize the brain and increase its plasticity. Beyond the psychedelic trip, its lasting effects offer hope in psychedelic medicine. With proper supervision, this substance could become a transformative therapeutic tool.<\/em><\/strong><\/p>\n\n\n\n

Reference:\u00a0<\/p>\n\n\n\n